Compare ALKS & PFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALKS | PFSI |
|---|---|---|
| Founded | 1987 | 2008 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 6.8B |
| IPO Year | 1991 | 2013 |
| Metric | ALKS | PFSI |
|---|---|---|
| Price | $28.11 | $134.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 7 |
| Target Price | $42.85 | ★ $145.43 |
| AVG Volume (30 Days) | ★ 1.6M | 293.2K |
| Earning Date | 02-11-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 0.91% |
| EPS Growth | 2.44 | ★ 191.00 |
| EPS | 2.02 | ★ 9.30 |
| Revenue | $1,521,338,000.00 | ★ $2,723,457,000.00 |
| Revenue This Year | N/A | $6.22 |
| Revenue Next Year | $24.22 | $28.90 |
| P/E Ratio | ★ $14.01 | $14.14 |
| Revenue Growth | 1.08 | ★ 21.25 |
| 52 Week Low | $25.17 | $85.74 |
| 52 Week High | $36.45 | $137.53 |
| Indicator | ALKS | PFSI |
|---|---|---|
| Relative Strength Index (RSI) | 43.40 | 58.95 |
| Support Level | $27.56 | $132.55 |
| Resistance Level | $28.63 | $134.91 |
| Average True Range (ATR) | 0.66 | 2.67 |
| MACD | 0.03 | -0.15 |
| Stochastic Oscillator | 38.62 | 71.38 |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform and integrated business focused on the production and servicing of U.S. residential mortgage loans. The company operates through two segments: production and servicing. The production segment performs loan origination, acquisition and sale activities. The servicing segment performs loan servicing for newly originated loans.